Company profile: oncgnostics
1.1 - Company Overview
Company description
- Provider of proprietary epigenetic biomarker-based in vitro diagnostic (IVD) tests for cancer screening, therapeutic decisions, and follow-up care, including GynTect and ScreenYu Gyn for detecting methylated DNA regions in cervical cells (ScreenYu Gyn suited for automation and large-scale screening), and saliva-based head and neck tumor diagnostics using DNA methylation markers.
Products and services
- GynTect: IVD-grade molecular assay for cervical cancer that identifies epigenetically methylated DNA regions in cervical cells to determine whether a treatable tissue change is present
- Head and Neck Tumor Diagnostics: Saliva-based epigenetic assays leveraging DNA methylation markers to detect cancer cells in saliva samples for early diagnosis of head and neck tumors
- ScreenYu Gyn: Automation-ready molecular assay for cervical cancer screening that detects a single methylated DNA region in cervical cells, suitable for automation and large-scale screening
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to oncgnostics
Vector BioMed
HQ: United States
Website
- Description: Provider of state-of-the-art custom vector design and GMP manufacturing, specializing in Lentiviral vector production for research, pre-clinical, IND-enabling, and clinical trials using a serum-free, chemically-defined process; algorithm-based vector design optimized for titer, transduction, and transgene expression; custom assay development; and support services for clinical development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vector BioMed company profile →
Athenix
HQ: United States
Website
- Description: Provider of crop science offerings in seeds, crop protection, and non-agricultural pest control, leveraging agricultural and industrial biotechnology and a gene-discovery infrastructure to develop products that meet real customer needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Athenix company profile →
Decipher Bio
HQ: United States
Website
- Description: Provider of genomic tests for urological cancers, including Decipher Prostate for risk scores to guide treatment decisions and Decipher Bladder for molecular subtyping to aid planning, and the Decipher GRID research platform of whole-transcriptome profiles. Continues to build its GRID database and partners with pharmaceutical companies to identify biomarkers of response to novel therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Decipher Bio company profile →
BostonGene
HQ: United States
Website
- Description: Provider of AI-powered molecular and immune profiling and a cloud-based platform for personalized cancer therapy analysis; multiplex immunofluorescence (MxIF) pipeline analyzing tissue architecture and cell interactions, detecting up to 40 protein markers; bioinformatics services using multi-omics databases and proprietary software; biopharma solutions and target analysis to evaluate drug candidates in a certified environment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BostonGene company profile →
WestBred
HQ: United States
Website
- Description: Provider of highest yield potential wheat seed designed for regional conditions, including certified single-variety seed containing no other crops, foreign material, or certain seed-borne diseases; Clearfield Plus production system for grass and broadleaf weed control using Beyond herbicide; grower resources such as optimal seeding rate guidance; intellectual property protection for varieties; and the National Wheat Yield Contest.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WestBred company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for oncgnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to oncgnostics
2.2 - Growth funds investing in similar companies to oncgnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for oncgnostics
4.2 - Public trading comparable groups for oncgnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →